Medically reviewed by Femi Aremu, PharmD Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs known as GLP-1 agonists used to treat people with type 2 diabetes. While some GLP ...

A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

As initial pharmacotherapy for type 2 diabetes, liraglutide was safe and effective and led to greater decreases in weight, blood pressure and hypoglycemic events. In a 52-week, phase-3 study ...

BALTIMORE — Liraglutide (Victoza, Novo Nordisk) added to metformin (with or without insulin) significantly reduced HbA 1c levels in obese 10- to 16-year-old children and adolescents with type 2 ...

Liraglutide (Victoza) for type 2 diabetes is exactly the same drug as Saxenda for weight loss, but Saxenda is a higher dose. Although the target for each formulation is the same ...

Liraglutide is a diabetes and weight loss drug. It’s approved for diabetes under the brand name Victoza and for weight loss under the brand name Saxenda, which uses a higher dose of liraglutide.

Regulatory agencies mandate that new drugs that have been approved for use in adults with type 2 diabetes undergo efficacy and safety trials in youth with the disease. 9,10 A phase 2 study of the ...

Novo Nordisk has launched Victoza (liraglutide [rDNA origin] injection), ... (GLP-1) analog, as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes. ...

Liraglutide, a first-in-class once-daily human glucagonlike peptide-1 analog, has received approval as second-line therapy for type 2 diabetes.